amikacin has been researched along with hr 810 in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 6 (60.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Carattoli, A; Ellington, MJ; Karisik, E; Livermore, DM; Underwood, A; Woodford, N | 1 |
| Girlich, D; Nordmann, P; Poirel, L | 1 |
| Klesel, N; Limbert, M; Seibert, G | 1 |
| Elkhaïli, H; Jehl, F; Kamili, N; Linger, L; Monteil, H; Pompei, D | 1 |
| Deguchi, K; Fukayama, S; Ishihara, R; Koguchi, M; Oda, S; Suzuki, Y | 1 |
| Jacolot, A; Louchahi, K; Mimoz, O; Padoin, C; Petitjean, O; Quillard, J; Samii, K; Tod, M | 1 |
| Elkhaïli, H; Jehl, F; Levêque, D; Linger, L; Monteil, H; Niedergang, S; Peter, JD; Pompei, D; Salmon, J; Salmon, Y; Thierry, RC | 1 |
| Canis, F; Cavallo, JD; Husson, MO | 1 |
| Bessho, M; Endo, K; Fukuda, M; Hirashima, K; Kawai, N; Kobayashi, Y; Tominaga, K | 1 |
1 trial(s) available for amikacin and hr 810
| Article | Year |
|---|---|
[Clinical evaluation of combination therapy with cefpirome and amikacin for infections associated with hematological disorders].
Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cefpirome; Cephalosporins; Drug Therapy, Combination; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Male; Middle Aged; Treatment Outcome | 1998 |
9 other study(ies) available for amikacin and hr 810
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25:H4-ST131 clone.
Topics: beta-Lactamases; Computational Biology; Escherichia coli; Models, Genetic; Molecular Sequence Data; Open Reading Frames; Plasmids; United Kingdom | 2009 |
First isolation of the blaOXA-23 carbapenemase gene from an environmental Acinetobacter baumannii isolate.
Topics: Acinetobacter baumannii; beta-Lactamases; DNA, Bacterial; Escherichia coli; France; Genes, Bacterial; Water Microbiology | 2010 |
Synergistic activity in vitro of the new cephalosporin antibiotic HR 810 with gentamicin and amikacin against multiresistant pathogens.
Topics: Amikacin; Anti-Bacterial Agents; Cefpirome; Cephalosporins; Drug Resistance, Microbial; Drug Synergism; Gentamicins; Kanamycin | 1984 |
[Kinetics of bactericidal activity of cefepime and cefpirome alone or combined with gentamicin, amikacin or ciprofloxacin against Acinetobacter baumannii, Stenotrophomonas maltophilia and Enterobacter cloacae hyperproductive in cephalosporinase].
Topics: Acinetobacter; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Cefepime; Cefpirome; Cephalosporinase; Cephalosporins; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enterobacter cloacae; Gentamicins; In Vitro Techniques; Xanthomonas | 1996 |
[Antibacterial activities of combination uses of cefpirome with various antibiotics in vitro against clinically isolated glucose non-fermentative gram-negative rods: part 1. the results against Pseudomonas aeruginosa].
Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Cefpirome; Cephalosporins; Drug Combinations; Drug Synergism; Gentamicins; Imipenem; Piperacillin; Pseudomonas aeruginosa; Tobramycin | 1996 |
Influence of experimental rat model of multiple organ dysfunction on cefepime and amikacin pharmacokinetics.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Cefpirome; Cephalosporins; Half-Life; Lung; Multiple Organ Failure; Rats | 1996 |
[In vivo pharmacokinetic of amikacin and its pharmacodynamic in combination with cefepime, cefpirome and meropenem in an in vitro/ex vivo micropig model].
Topics: Amikacin; Animals; Anti-Bacterial Agents; Cefepime; Cefpirome; Cephalosporins; Disease Models, Animal; Drug Therapy, Combination; Female; Humans; In Vitro Techniques; Klebsiella pneumoniae; Meropenem; Perfusion; Serum Bactericidal Test; Swine; Thienamycins | 1997 |
[Evaluation of bactericidal activity of cefpirome-aminoglycoside combination against Pseudomonas aeruginosa strains with intermediate sensitivity to cefpirome and in various phenotypes of beta-lactam resistance].
Topics: Amikacin; Anti-Bacterial Agents; Cefpirome; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; In Vitro Techniques; Microbial Sensitivity Tests; Phenotype; Pseudomonas aeruginosa; Tobramycin | 1997 |